PD-L1 expression and overall survival in Asian and western patients with gastric cancer

被引:3
|
作者
Rha, Sun Young [1 ,2 ]
Ku, Geoffrey Y. [3 ]
Kim, Hyo Song [1 ]
Chung, Hyun Cheol [1 ,2 ]
Amlashi, Fatemeh Ghazanfari [4 ]
Maru, Dipen Maheshbhai [4 ]
Fein, Carly A. [3 ]
Tang, Laura H. [3 ]
Zhou, Wei [5 ]
Wu, Ting [5 ]
Peter, Senaka A. [5 ]
Kelsen, David P. [3 ]
Ajani, Jaffer A. [4 ]
机构
[1] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Songdang Inst Canc Res, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Merck & Co Inc, 126 E Lincoln Ave, Rahway, NJ 07065 USA
关键词
expression; gastric cancer; overall survival; prognosis; PD-L1; LIGAND; 1; EXPRESSION; T-CELL EXCLUSION; PROGNOSTIC-SIGNIFICANCE; UNITED-STATES; EAST; HETEROGENEITY;
D O I
10.2217/fon-2022-0103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Data are limited on PD-L1 expression and its association with overall survival (OS) in gastric cancer (GC) patients receiving routine care in different regions. Materials & methods: In a retrospective study, PD-L1 expression was assayed using the 22C3 pharmDx on GC tumor samples collected between 2003 and 2017 at South Korean and US cancer centers. PD-L1 positivity was defined as combined positive score (CPS) >= 1. The relationship between PD-L1 and OS was analyzed. Results: Of 574 GC tumor samples, 67.4% were CPS >= 1 (68.7% in Korean and 65.7% in US patients). PD-L1 expression was not associated with OS (adjusted hazard ratio: 0.94; 95% CI: 0.75-1.17). Conclusion: PD-L1 prevalence and its association with OS was similar between South Korean and US GC patients.
引用
收藏
页码:2623 / 2634
页数:12
相关论文
共 50 条
  • [1] Identification of Malassezia globosa as a Gastric Fungus Associated with PD-L1 Expression and Overall Survival of Patients with Gastric Cancer
    Zhang, Zhenzhan
    Qiu, Yaopeng
    Feng, Hao
    Huang, Donghua
    Weng, Binshu
    Xu, Zhou
    Xie, Qingfeng
    Wang, Zhe
    Ding, Wenfu
    Li, Guoxin
    Liu, Hao
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [2] Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer
    Fang, Wenfeng
    Chen, Ying
    Sheng, Jin
    Zhou, Ting
    Zhang, Yaxiong
    Zhan, Jianhua
    Liu, Lin
    Huang, Jiaxing
    Peng, Peijian
    Zhang, Li
    JOURNAL OF CANCER, 2017, 8 (09): : 1579 - 1585
  • [3] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer
    Wang, Weili
    Liao, Ping
    He, Yijing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1379 - 1381
  • [4] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer
    Weili Wang
    Ping Liao
    Yijing He
    Cancer Immunology, Immunotherapy, 2017, 66 : 1379 - 1381
  • [5] Expression of PD-L1 in gastric cancer
    Polushkina, T.
    Sotnikova, T.
    Kalinin, D.
    Danilova, N.
    VIRCHOWS ARCHIV, 2024, 485 : S499 - S499
  • [6] PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
    Boeger, Christine
    Behrens, Hans-Michael
    Mathiak, Micaela
    Krueger, Sandra
    Kalthoff, Holger
    Roecken, Christoph
    ONCOTARGET, 2016, 7 (17) : 24269 - 24283
  • [7] Overall Survival and PD-L1 Expression in Metastasized Malignant Melanoma
    Gadiot, Jules
    Hooijkaas, Anna I.
    Kaiser, Andrew D. M.
    van Tinteren, Harm
    van Boven, Hester
    Blank, Christian
    CANCER, 2011, 117 (10) : 2192 - 2201
  • [8] Overall survival and PD-L1 expression in patients with recurrent or metastatic head and neck cancer treated with nivolumab
    Okamoto, Isaku
    Sato, Hiroki
    Tsukahara, Kiyoaki
    AURIS NASUS LARYNX, 2020, 47 (04) : 676 - 686
  • [9] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [10] PD-L1 expression in patients with metastatic gastric cancer in South Korea
    Kim, Hyo Song
    Wu, Ting
    Kim, Hyunki
    Chung, Hyun Cheol
    Ajani, Jaffer A.
    Ku, Geoffrey Yuyat
    Kelsen, David Paul
    Zhu, Xingshu
    Savage, Mary J.
    Koshiji, Minori
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35